Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy on Stage IVB Ovarian Cancer With Supradiaphragmatic Lymph Node Metastasis

NCT05005650 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05005650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy on Stage IVB Ovarian Cancer With Supradiaphragmatic Lymph Node Metastasis
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
December 31, 2021
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastases, ovarian cancer stage iv